PubMed Health⌕ Search

PubMed · 14716050

Reference database for dual X-ray and laser Calscan bone densitometer.

Abstract

The new dual X-ray and laser technology (DXL) gives a more accurate determination of bone mineral density (BMD) than ordinary dual X-ray absorptiometry (DXA) technology because of the ability to eliminate fat tissue both inside and outside the measured bone. In this study the reference database for BMD measured at the calcaneus by the DXL Calscan device is reported. The database was obtained from 993 healthy women and 459 healthy men in a population from southern Sweden. Inclusion criteria were: healthy Swedish Caucasians, 15-85 yr of age for women and 19-85 yr of age for men, no history of osteoporosis treatment, no use of corticosteroids for more than 3 mo, and no extended bed rest. The young adult reference mean BMD for women was found to be 0.483 +/- 0.062 g/cm2 and for men 0.556 +/- 0.074 g/cm2. The age-adjusted odds ratio was 3.7 for a history of fracture among women aged 50 yr and over, comparing subjects with a 1-SD reduction in bone density to subjects with a bone density above this value. The DXL Calscan device used for the study was calibrated weekly against a heel bone phantom. The precision of these measurements was 0.5%. The in vivo precision was 1.2%, as assessed by duplicate measurements on 35 healthy individuals (mean age 52 yr, range 25-72 yr).

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ragnar Kullenberg. 2003. Reference database for dual X-ray and laser Calscan bone densitometer.. https://doi.org/10.1385/jcd%3A6%3A4%3A367

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A repeated measures concordance correlation coefficient.

The concordance correlation coefficient is commonly used to assess agreement between two raters or two methods of measuring a response when the data are measured on a continuous scale. However, the situation may arise in which repeated measurements are taken for each rater or method, e.g. longitudinal studies in clinical trials or bioassay data with subsamples. This paper proposes a coefficient for measuring agreement between two raters or two methods of measuring a response in the presence of repeated measurements. We illustrate the methodology with examples comparing (1) 1-hr versus 2-hr blood draws for measuring cortisol in an asthma clinical trial and (2) two measurements of percentage body fat, from skinfold calipers and dual energy X-ray absorptiometry.

Absorptiometry, Photon↗

Crystallization and preliminary X-ray analysis of a domain in the Runx2 transcription factor that interacts with the 1alpha,25 dihydroxy vitamin D3 receptor.

The Runx2 transcription factor is a key regulator of osteoblast differentiation. In response to 1alpha,25 dihydroxy vitamin D3, Runx2 may interact with the 1alpha,25 dihydroxy vitamin D3 receptor (VDR) in the promoter of target genes, producing a synergic activation of their transcription. Previous studies have suggested that the motifs responsible for the VDR-Runx2 interaction are contained within the 230-361 domain of Runx2. In this work, we confirmed by GST-pull down that Runx2(I(209-361)) is sufficient to interact with the VDR. To obtain structural information, GST-Runx2(I(209-361)) protein was overexpressed in Escherichia coli, purified and crystallized using the hanging-drop vapor-diffusion method and polyethyleneglycol as a precipitant. The crystals were found to diffract to a maximum resolution of 2.7 A and a complete data set to a 3.3 A resolution was collected and analyzed. The crystals belong to the tetragonal system, with a space group P4 and unit-cell parameters of a = b = 90.8, and c = 57.2 A. The presence of a monomer of the recombinant GST-Runx2(I(209-361)) in the asymmetric unit gives a V(M) of 2.7 A(3) Da(-1) and a solvent content of 54.8%.

Absorptiometry, Photon↗

Quantifying the treatment effect explained by markers in the presence of measurement error.

Surrogate markers or intermediate markers are important in identifying subjects with high risk of a serious disease or for monitoring disease progression of a subject on treatment. Quantifying the proportion of treatment effect (PTE) explained by markers has been studied extensively. Due to reasons such as biological variation, limited machine precision, etc. markers are generally measured with error. The estimated PTE ignoring the measurement error could be biased, which may lead to incorrect conclusions. In this article, we adjust for the measurement error using regression calibration to construct a less biased estimator of excess relative odds, a quantity to measure the treatment effect explained by markers. The method is applied to data from a clinical study in osteoporosis.

Absorptiometry, Photon↗